Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |